Key facts
- Notable investors include Malaysian Technology Development Corporation, University of Malaya.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for BioApps
- ·The full record, as it builds
Funding rounds
No funding rounds for BioApps are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioApps
Operator of a prosthetic and orthotic manufacturing and consulting company intended for transtibial, ankle disarticulation, transfemoral, knee disarticulation, and foot amputations. The company offers fake legs, upper and lower limb prosthetics, shoe modifications, and diabetic shoes, enabling public and private hospitals with artificial limbs, custom-made shoes, and insoles.
- Sector
- Healthcare
- HQ
- Kuala Lumpur, Malaysia
- Founded
- 2012
- Employees
- 33
- Website
- bioapps.com.my/
- Ownership
- Privately Held (backing)
BioApps doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioApps shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioApps in its N-PORT filings yet. We sweep new filings monthly.